Pancreatic Enzyme Replacement Therapy: Drugs
Commons · Question 34168 · Tabled 26 Feb 2025 · Department of Health and Social Care · Official record
Answered 7 Mar 2025
Question
Asked by Edward Morello
To ask the Secretary of State for Health and Social Care, what (a) guidance and (b) support his Department has made available to healthcare professionals on the management of patients impacted by pancreatic enzyme replacement therapy medications shortages
Answer
Answered by Karin Smyth, 7 Mar 2025
The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Through this work we have managed to secure additional volumes of PERT for 2025. The Department has...